» Articles » PMID: 25489966

Myeloid-specific Fos-related Antigen-1 Regulates Cigarette Smoke-induced Lung Inflammation, Not Emphysema, in Mice

Overview
Date 2014 Dec 10
PMID 25489966
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Heightened lung inflammation is a cardinal feature of chronic obstructive pulmonary disease (COPD). Cigarette smoke (CS)-induced macrophage recruitment and activation, accompanied by abnormal secretion of a number of inflammatory cytokines and matrix metalloproteinases, play a major role in the pathophysiology of COPD. The Fos-related antigen-1 (Fra-1) transcription factor differentially regulates several cellular processes that are implicated in COPD, such as inflammation and immune responses, cell proliferation and death, and extracellular remodeling. Although CS stimulates Fra-1 expression in the lung, the precise role of this transcription factor in the regulation of CS-induced lung inflammation in vivo is poorly understood. Here, we report that myeloid-specific Fra-1 signaling is important for CS-induced lung macrophagic inflammatory response. In response to chronic CS exposure, mice with Fra-1 specifically deleted in myeloid cells showed reduced levels of CS-induced lung macrophagic inflammation, accompanied by decreased expression levels of proinflammatory cytokines compared with their wild-type counterparts. Consistent with this result, bone marrow-derived Fra-1-null macrophages treated with CS showed decreased levels of proinflammatory mediators and matrix metalloproteinases. Interestingly, deletion of Fra-1 in myeloid cells did not affect the severity of emphysema. We propose that Fra-1 plays a key role in promoting chronic CS-induced lung macrophagic inflammation in vivo, and that targeting this transcription factor may be useful in dampening persistent lung inflammation in patients with COPD.

Citing Articles

Regulation Networks of Non-Coding RNA-Associated ceRNAs in Cisplatin-Induced Acute Kidney Injury.

Ding Y, Wan S, Liu W, Lu Y, Xu Q, Gan Y Cells. 2022; 11(19).

PMID: 36230932 PMC: 9563924. DOI: 10.3390/cells11192971.


The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.

He Y, Zhou H, Chen L, Wang Y, Xie W, Xu Z Front Immunol. 2022; 13:954744.

PMID: 36032067 PMC: 9404335. DOI: 10.3389/fimmu.2022.954744.


Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients.

Che L, Chen G, Cai X, Xie Z, Xia T, Zhang W Biomed Res Int. 2022; 2022:1806427.

PMID: 35747501 PMC: 9211381. DOI: 10.1155/2022/1806427.


Determining Pharmacological Mechanisms of Chinese Incompatible Herbs Fuzi and Banxia in Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study.

Ni K, Cai X, Chen Y, Zhou L, Chen R, Zheng S Evid Based Complement Alternat Med. 2021; 2020:8365603.

PMID: 33488748 PMC: 7790578. DOI: 10.1155/2020/8365603.


Expression and function of FRA1 protein in tumors.

Jiang X, Xie H, Dou Y, Yuan J, Zeng D, Xiao S Mol Biol Rep. 2019; 47(1):737-752.

PMID: 31612408 DOI: 10.1007/s11033-019-05123-9.

References
1.
Qu P, Du H, Wang X, Yan C . Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res. 2009; 69(18):7252-61. PMC: 2753283. DOI: 10.1158/0008-5472.CAN-09-0577. View

2.
Rangasamy T, Cho C, Thimmulappa R, Zhen L, Srisuma S, Kensler T . Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004; 114(9):1248-59. PMC: 524225. DOI: 10.1172/JCI21146. View

3.
Schonthaler H, Guinea-Viniegra J, Wagner E . Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011; 70 Suppl 1:i109-12. DOI: 10.1136/ard.2010.140533. View

4.
Herold S, Mayer K, Lohmeyer J . Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol. 2012; 2:65. PMC: 3342347. DOI: 10.3389/fimmu.2011.00065. View

5.
Shapiro S . The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160(5 Pt 2):S29-32. DOI: 10.1164/ajrccm.160.supplement_1.9. View